Filed 1.2y ago· Apr 8, 2025
12 days to disclose
Greg Landsman
DHouseOhio-01
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+2.4% vs S&P 500
Trade dateMar 27, 2025
Common Stock
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–9 of 9
Filed 1.5y ago· Dec 12, 2024
34 days to discloseGreg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$15K-$50K
−1.1% vs S&P 500
Trade dateNov 8, 2024
⚑ Pharmaceutical
Filed 1.6y ago· Nov 14, 2024
30 days to discloseGreg Landsman
DHouseOhio-01
↓sold
Regeneron Pharmaceuticals
REGN
$1K-$15K
−2.8% vs S&P 500
Trade dateOct 15, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.6y ago· Nov 14, 2024
30 days to discloseGreg Landsman
DHouseOhio-01
↓sold
Pfizer
PFE
$15K-$50K
−2.8% vs S&P 500
Trade dateOct 15, 2024
Pfizer, Inc.
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
72 days to disclose · 27 past 45-day windowGreg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$1K-$15K
+28.9% vs S&P 500
Trade dateJun 3, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
369 days to disclose · 324 past 45-day windowGreg Landsman
DHouseOhio-01
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
−24.1% vs S&P 500
Trade dateAug 11, 2023
Common Stock
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
461 days to disclose · 416 past 45-day windowGreg Landsman
DHouseOhio-01
↑bought
Eli Lilly
LLY
$1K-$15K
+130.1% vs S&P 500
Trade dateMay 11, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
559 days to disclose · 514 past 45-day windowGreg Landsman
DHouseOhio-01
↓sold
Eli Lilly
LLY
$1K-$15K
+11.6% vs S&P 500
Trade dateFeb 2, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 14, 2024
574 days to disclose · 529 past 45-day windowGreg Landsman
DHouseOhio-01
↑bought
Eli Lilly
LLY
$1K-$15K
+188.1% vs S&P 500
Trade dateJan 18, 2023
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 8, 2025 1.2y ago | Greg Landsman DHouseOhio-01 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Mar 27, 2025 12 days to disclose | Flat·+0.0% +2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2024 1.5y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Nov 8, 2024 34 days to disclose | Flat·+0.0% −1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 14, 2024 1.6y ago | Greg Landsman DHouseOhio-01 | ↓sold | Regeneron Pharmaceuticals REGN Common Stock ⚑ Pharmaceutical · Energy and Commerce | Oct 15, 2024 30 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 14, 2024 1.6y ago | Greg Landsman DHouseOhio-01 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Energy and Commerce | Oct 15, 2024 30 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jun 3, 2024 72 days to disclose · 27 past 45-day window | Missed gain·−$507-6.3% +28.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock ⚑ Pharmaceutical · Energy and Commerce | Aug 11, 2023 369 days to disclose · 324 past 45-day window | Bad buy·−$1.2K-14.6% −24.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | May 11, 2023 461 days to disclose · 416 past 45-day window | Good buy·+$11.4K+142.3% +130.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Feb 2, 2023 559 days to disclose · 514 past 45-day window | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2024 1.8y ago | Greg Landsman DHouseOhio-01 | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Energy and Commerce | Jan 18, 2023 574 days to disclose · 529 past 45-day window | Good buy·+$16K+199.8% +188.1% vs S&P 500 | $1K-$15K midpoint $8K |